Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term endothelial permeability regulators refers to a broad functional class of molecules rather than a single therapeutic target. This group encompasses a diverse array of proteins, including growth factors like Vascular Endothelial Growth Factor (VEGF), signaling lipids such as Sphingosine-1-phosphate (S1P), and structural components of the endothelial barrier like VE-cadherin and claudins. These regulators maintain the integrity of the vascular endothelium, which controls the passage of fluids, ions, and cells between the blood and surrounding tissues. Dysregulation of these pathways is a hallmark of various pathologies, including acute respiratory distress syndrome (ARDS), diabetic retinopathy, and tumor-associated edema. Because this term describes a physiological process involving multiple distinct receptors and enzymes, it is considered too broad to be classified as a specific drug target; instead, individual members of this class are targeted for therapeutic intervention.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial permeability regulators.